Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Vaccines approved by the FDA are at least a million times safer than the viruses that they prevent

For more than 200 years, vaccines have played an important role in the prevention of infectious diseases.

2 Aug 2007

Study of therapeutic vaccine shows promise for metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

1 Aug 2007

Recent research into HPV and cervical cancer

The development of the first vaccine for the prevention of cancer came 30 years after Harald zur Hausen first hypothesized that human papilloma virus (HPV) might be associated with cervical cancer.

1 Aug 2007

Claim construction decision issued in Digene's patent case

Digene Corp. has announced that the U.S. District Court for the Western District of Wisconsin issued a pre-trial claim construction decision in the pending litigation between Digene and Third Wave Technologies, Inc. In that litigation, Digene alleges that Third Wave infringes its U.S. Patent No. 5,643,715 covering probes and methods for detecting human papillomavirus (HPV) type 52, a high-risk type of HPV.

26 Jul 2007

Court dismisses Gen-Probe court action against Digene

Digene Corp. has announced that a California state court has dismissed a complaint filed against the company by Gen-Probe, Inc., without option to amend. Gen-Probe's complaint asked the court to declare that an agreement between Gen-Probe and F. Hoffman-LaRoche Ltd.

23 Jul 2007

GSK's Cervarix receives positive opinion in Europe

GlaxoSmithKline has announced that its cervical cancer candidate vaccine received a positive opinion from the European Committee for Human Medicinal Products (CHMP) for the prevention of precancerous lesions (high grade cervical intraepithelial neoplasia - CIN grades 2 and 3) and cervical cancer causally related to human papillomavirus types 16 and 18.

19 Jul 2007

Do vaccines promote a false sense of security?

A new study examines whether a vaccine that offers only partial protection can backfire by increasing risky behavior, as a false sense of security could make recipients less careful than they otherwise would be.

16 Jul 2007

Are we looking at cancer vaccine trials the wrong way?

Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment.

4 Jul 2007

Rethinking therapeutic cancer vaccine trials

3 Jul 2007

Cervarix vaccine provides broad protection against cervical cancer

Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.

29 Jun 2007

Trial shows CERVARIX cervical cancer candidate vaccine effective

Results from an interim analysis of a Phase III study show that CERVARIX, the GlaxoSmithKline (GSK) cervical cancer candidate vaccine, provides up to 100 percent protection against advanced precancerous lesions caused by the most common types of human papillomavirus, types 16 and 18.

28 Jun 2007

Requiring HPV vaccination for school-age girls for upcoming school year 'too soon,' researcher says

It is premature to require middle-school age girls to receive Merck's human papillomavirus vaccine Gardasil for the upcoming school year, Doug Lowy -- head of the National Cancer Institute's Laboratory of Cellular Oncology and one of the scientists responsible for the development of the vaccine -- said on Wednesday, CQ HealthBeat reports (Bartolf, CQ HealthBeat, 6/20).

22 Jun 2007

Blood test may help signal tumor's remission, return in throat cancer patients

A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research .

3 Jun 2007

International studies show high efficacy for Gardasil

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.

1 Jun 2007

U.S. parents not in favor of HPV vaccine mandates

While debate in several state governments continues to grow over school mandates for Gardasil – a vaccine recommended by the Centers for Disease Control and Prevention for girls ages 11 to 12 that is designed to provide protection against human papillomavirus, or HPV, the virus linked to cervical cancer and genital warts – the majority of U.S. parents have already reached a decision on the issue: They do not want the vaccine to be mandated.

24 May 2007

Oral sex 'ups' the risk of throat cancer

According to scientists in the U.S. a virus contracted through oral sex is the cause of some throat cancers.

14 May 2007

Human papillomavirus linked to throat cancers

Researchers at the Johns Hopkins Kimmel Cancer Center have conclusive evidence that human papillomavirus (HPV) causes some throat cancers in both men and women.

10 May 2007

Some physicians not purchasing, restricting recipients of Gardasil because of cost, Washington Post reports

Inadequate reimbursement from insurance companies for Merck's human papillomavirus vaccine Gardasil is leading some physicians to refuse to purchase the vaccine and restricting the recipients to those whose insurers have agreed to pay a "reasonable" fee, the Washington Post reports (Boodman, Washington Post , 5/1).

2 May 2007

Fred Hutchinson Cancer Research Center establishes new vaccine and disease institute

Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer.

2 May 2007

Texas Legislature passes bill to halt Gov. Perry's executive order mandating HPV vaccine

The Texas House on Wednesday voted 135-2 to pass ( HB 1098 ) a Senate-approved bill that would prevent mandatory vaccination for middle school girls in the state until 2011, the New York Times reports (Blumenthal, New York Times , 4/26).

30 Apr 2007